FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, particularly to abdominal surgery and to the treatment of ventral hernia repair patients. Disclosed is use of hydroxyethyl dimethyldihydropyrimidine (xymedon) for acceptance stimulation of mesh implant after plasty of ventral hernias and corresponding method of stimulation of mesh implant, including its introduction.
EFFECT: technical result consists in reduction of inflammatory and improving immune reaction to surgical aggression and implant, which leads to reduction of postoperative complications.
7 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE AND METHOD FOR COMBINED APPARATUS-PHARMACOLOGICAL SEPARATION OF MUSCULAR-FASCIAL COMPONENTS OF ABDOMINAL WALL IN SURGICAL MANAGEMENT OF POSTOPERATIVE VENTRAL HERNIAS | 2021 |
|
RU2824801C2 |
| METHOD OF PREVENTING WOUND POSTOPERATIVE COMPLICATIONS OF ALLOHERNIOPLASTY OF ANTERIOR ABDOMINAL WALL | 2023 |
|
RU2809913C1 |
| METHOD OF PREVENTING WOUND COMPLICATIONS AFTER PROSTHETIC HERNIOPLASTY IN CASE OF INFRINGEMENT OF VENTRAL HERNIAS | 2011 |
|
RU2455947C1 |
| METHOD FOR PREVENTION OF WOUND COMPLICATIONS FOLLOWING REPLACING INGUINAL HERNIOPLASTY | 2011 |
|
RU2469654C1 |
| METHOD OF PROPHYLAXIS OF NADAPONEUROTIC PLASTICS OF POSTOPERATIVE VENTRAL HERRY COMPLICATIONS | 2017 |
|
RU2645245C1 |
| MEDICINAL PRODUCT FOR OPTIMISING THE SURVIVAL OF A SILICONE IMPLANT AFTER RECONSTRUCTIVE-REPARATIVE BREAST SURGERY | 2022 |
|
RU2788259C1 |
| METHOD FOR PREPERITONEAL BLOCK FOLLOWING MEDIAN POSTOPERATIVE VENTRAL HERNIOPLASTY | 2012 |
|
RU2529412C2 |
| METHOD FOR PREVENTION OF INFECTIOUS COMPLICATIONS IN PROSTHETIC HERNIOPLASTY OF POSTOPERATIVE VENTRAL HERNIAS | 2022 |
|
RU2787919C1 |
| METHOD FOR TREATING POSTOPERATIVE VENTRAL HERNIAS | 2002 |
|
RU2215484C2 |
| METHOD OF HERNIA SECTION WITH PROSTHETIC CORRECTING PLASTY IN PATIENTS WITH STRANGULATED POSTOPERATIVE VENTRAL HERNIAS | 2011 |
|
RU2486871C1 |
